The effect of Lazaroid U-74389G on extended liver resection with ischemia in dogs

Surgery

Volumn 126, Issue 5, 1999, Pages 908-917

  Iwanami, Kotaro ^b   Takeyoshi, Izumi ^a   Ohwada, Susumu ^b   Kobayashi, Junya ^b   Kawashima, Yoshiyuki ^b   Aiba, Masaaki ^b   Matsumoto, Koshi ^b   Morishita, Yasuo ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HYALURONIC ACID; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; LAZ G; LAZAROID; MESSENGER RNA; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; DRUG EFFICACY; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION; LIVER ISCHEMIA; LIVER PROTECTION; LIVER RESECTION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032692971     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70032-2     Document Type: Article

References (43)

1. 1. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987;262:10438-40.
2. 2. Shenkar R, Abraham E. Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression Following hemorrhage and resuscitation. Crit Care Med 1995;23:132-9.
3. 3. Meyer RJ, Juarez RA, Holden WE. 21-aminosteroids protect endothelial cells against injury by neutrophils. Am Rev Respir Dis 1992;145:A571.
4. 4. Gadaleta D, Verma M, Davis JM. Inhibition of neutrophil leukotriene generation by the 21-aminosteroid, U-74389F. J Surg Res 1994;57:233-7.
5. 5. Anderson DK, Braughler JM, Hall ED, Waters TR, McCall JM, Means ED. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J Neurosurg 1988;69:562-7.
6. 6. Hall ED, Yonkers PA. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 1988;19:340-4.
7. 7. Cosenza CA, Cramer DV, Cunneen SA, Tuso PJ, Wang HK, Makowka L. Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology 1994;19:418-25.
8. 8. Shackleton CR, Ettinger SL, Scudamore CH, Toleikis PF, Keown PA. Effect of a 21-aminosteroid, U74006F, on lipid peroxidation and glomerulotubular function following experimental renal ischemia, J Surg Res 1994;57:433-7.
9. 9. Todo S, Hamada N, Zhu Y, Zhang S, Subbotin V, Nemoto A, et al. Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation 1996;61:189-94.
10. 10. Haynes J, Seibert A, Bass JB, Taylor AE. U74500A inhibition of oxidant-mediated lung injury. Am J Physiol 1990;283:11144-8.
11. 11. Badylak SF, Lantz GC, Jeffries M. Prevention of reperfusion injury in surgically induced gastric dilatation-volvulus in dogs. Am J Vet Res 1990;51:294-9.
12. 12. Killinger WA, Dorofi DB, Keagy BA, Johnson G. Improvement of endothelial cell viability at 4°C by addition of lazaroid U74500A to preservation solutions. Transplantation 1992;53:983-6.
13. 13. Katz SM, Sun S, Schechner RS, Tellis VA, Alt ER, Greenstein SM. Improved small intestinal preservation after lazaroid U74389G treatment and cold storage in University of Wisconsin solution. Transplantation 1995;59:694-8.
14. 14. Xu HS, Stevenson WC, Pruett TL, Jones RS. Donor lazaroid pretreatment improves viability of livers harvested from non-heart-beating rats. Am J Surg 1996;171:113-7.
15. 15. Kurashige S, Akuzawa Y, Yoshida T, Teshima C, Mitsuhashi S. Purine metabolic enzymes in lymphocytes. I. adenosine deaminase and purine nucleoside phosphorylase activities in mouse lymphocyte subpopulations. Microbiol Immunol 1982;26:77-85.
16. 16. Kondo T, Chichibu K, Usuki H, Matsuura T, Shichijo S, Yokoyama M. Rapid assay of hyaluronic acid in serum. Jpn J Clin Pathol 1991;39:536-40.
17. 17. Ohishi N, Ohkawa H, Mike A, Tatano T, Yagi K. A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int 1985;10:205-11.
18. 18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
19. 19. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
20. 20. Ekberg H, Tranberg KG, Andersson R, Jeppsson B, Bengmark S. Major liver resection: perioperative course and management. Surgery 1986;100:1-7.
21. 21. Nagorney DM, Heerden JA, Ilstrup DM, Adson MA. Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989;106:740-9.
22. 22. Suzuki S, Toled-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation 1993;55:1265-72.
23. 23. Jaeschke H, Farhood A, Smith CW. Neutrophils coutribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-9.
24. 24. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:1269-75.
25. 25. Ernster L. Biochemistry of reoxygenation injury. Crit Care Med 1988;16:947-53.
26. 26. Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation: importance of ferric to ferrous ratios in initiation. J Biol Them 1986;261:102:82-9.
27. 27. Gadaleta D, Verma M, Davis JM, Inhibition of neutrophil leukotriene generation by the 21-aminosteroid lipid, U74389F. J Surg Res 1994;57:233-7.
28. 28. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991;13:364-75.
29. 29. Colletti LM, Burtch GD, Remick DG, Kunkel SL, Strieter RM, Guice KS, et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1990;49:268-72.
30. 30. Levitt MA, Sievers RE, Wolfe CL. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U74500A, a nonglucocorticoid 21-aminosteroid. J Cardiovasc Pharmacol 1994;23:136-40.
31. 31. Tomizawa N, Ohwada S, Ohya T, Takahashi T, Ichikawa H, Kobayashi J, et al. Effects of neutrophil elastase inhibitor on reperfusion injury in the canine liver. Transplant Proc 1996;28:1767-8.
32. 32. Kobayashi J, Takeyoshi I, Ohwada S, Iwanami K, Matsumoto K, Muramoto M, et al. The effect of FR167653 in extended liver resection with ischemia in dogs. Hepatology 1998;28:459-65.
33. 33. Fleishaker JC, Peters GR, Cathcart KS. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger. single-dose administration. J Clin Pharmacol 1993;33:175-81.
34. 34. Shimizu H, He W, Guo P, Dziadkoviec I, Miyazaki M, Falk RE. Serum hyaluronate in the assessment of liver endothelial cell function after orthotopic liver transplantation in the rat. Hepatology 1994;20:1323-9.
35. 35. Rao PN, Walsh TR, Makowka L, Rubin RS, Weber T, Snyder JT, et al. Purine nucleoside phosphorylase: a new marker for free oxygen radical injury to the endothelial cell. Hepatology 1990;11:193-8.
36. 36. Mischinger HJ, Rao PN, Todo S, Snyder JT, Quehenberger F, Murase N, et al. Levels of purine nucleoside phosphorylase (PNP) as a viability marker of nonparenchymal cells in cold preserved livers. Transplant Proc 1991;23:222-5.
37. 37. Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993;104:1466-71.
38. 38. Brass CA, Mody MG. Evaluation of purine nucleoside phosphorylase release as a measure of hepatic endothelial cell injury. Hepatology 1995;21:174-9.
39. 39. Itasaka H, Suehiro T, Wakiyama S, Yanaga K, Shimada M, Sugimachi K. Significance of hyaluronic acid for evaluation of hepatic endothelial cell damage after cold preservation/reperfusion. J Surg Res 1995;59:589-95.
40. 40. Pollard SG, Forbes MA, Metcalfe SM, Cooper EH, Calne RY. Hyaluronic acid in the assessment of liver graft function. Transplant Proc 1990;22:2301-2.
41. 41. Deaciuc IV, Bagby GJ, Lang CH, Spitzer JJ. Hyaluronic acid uptake by the isolated, perfused rat liver: an index of hepatic sinusoidal endothelial cell function. Hepatology 1993;17:266-72.
42. 42. Sankary HN, Chong A, Foster P, Brown E, Shen J, Kimura R, et al. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology 1995;22:1236-42.
43. 43. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317-23.